Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Other Non-Current Assets (2021 - 2022)

Historic Other Non-Current Assets for Bioventus (BVS) over the last 2 years, with Q4 2022 value amounting to $406.0 million.

  • Bioventus' Other Non-Current Assets rose 71198.8% to $406.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $406.0 million, marking a year-over-year increase of 71198.8%. This contributed to the annual value of $406.0 million for FY2022, which is 71198.8% up from last year.
  • Bioventus' Other Non-Current Assets amounted to $406.0 million in Q4 2022, which was up 71198.8% from $50.0 million recorded in Q2 2022.
  • In the past 5 years, Bioventus' Other Non-Current Assets registered a high of $406.0 million during Q4 2022, and its lowest value of $50.0 million during Q4 2021.